Literature DB >> 23830228

Words of wisdom: re: androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines.

Jun Luo1, Kenneth J Pienta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23830228     DOI： 10.1016/j.eururo.2013.05.012

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  4 in total

Review 1.  Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting.

Authors:  E S Antonarakis; A J Armstrong; S M Dehm; J Luo
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-05-17       Impact factor: 5.554

Review 2.  The importance of non-nuclear AR signaling in prostate cancer progression and therapeutic resistance.

Authors:  Jelani C Zarif; Cindy K Miranti
Journal:  Cell Signal       Date:  2016-01-29       Impact factor: 4.315

Review 3.  Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects.

Authors:  R Ferraldeschi; J Welti; J Luo; G Attard; J S de Bono
Journal:  Oncogene       Date:  2014-05-19       Impact factor: 9.867

4.  Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model.

Authors:  H G Nguyen; J C Yang; H-J Kung; X-B Shi; D Tilki; P N Lara; R W DeVere White; A C Gao; C P Evans
Journal:  Oncogene       Date:  2014-03-24       Impact factor: 9.867
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.